| E20 |
Hypoparathyroidism [+]
| Excludes 1: |
Di George's syndrome (D82.1)
postprocedural hypoparathyroidism (E89.2)
tetany NOS (R29.0)
transitory neonatal hypoparathyroidism (P71.4)
|
|
|
| E20.0 |
Idiopathic hypoparathyroidism
|
| E20.1 |
Pseudohypoparathyroidism
|
| E20.8 |
Other hypoparathyroidism [+]
|
|
| E20.81 |
Hypoparathyroidism due to impaired parathyroid hormone secretion [+]
|
|
| E20.810 |
Autosomal dominant hypocalcemia
Autosomal dominant hypocalcemia type 1 (ADH1)
Autosomal dominant hypocalcemia type 2 (ADH2)
| Code also |
, if applicable, any associated conditions, such as:
calculus of kidney (N20.0)
chronic kidney disease (N18.-)
respiratory distress (J80, R06.-)
seizure disorder (G40.-, R56.9)
|
|
| E20.811 |
Secondary hypoparathyroidism in diseases classified elsewhere
| Code first |
underlying condition, if known
|
|
| E20.812 |
Autoimmune hypoparathyroidism
| Code first |
, if applicable, underlying condition such as:
autoimmune polyglandular failure (E31.0)
Schmidt's syndrome (E31.0)
|
|
| E20.818 |
Other specified hypoparathyroidism due to impaired parathyroid hormone secretion
Familial isolated hypoparathyroidism
|
| E20.819 |
Hypoparathyroidism due to impaired parathyroid hormone secretion, unspecified
|
|
| E20.89 |
Other specified hypoparathyroidism
Familial hypoparathyroidism
|
|
| E20.9 |
Hypoparathyroidism, unspecified
Parathyroid tetany
|
|
| E21 |
Hyperparathyroidism and other disorders of parathyroid gland [+]
| Excludes 1: |
adult osteomalacia (M83.-)
ectopic hyperparathyroidism (E34.2)
hungry bone syndrome (E83.81)
infantile and juvenile osteomalacia (E55.0)
|
| Excludes 2: |
familial hypocalciuric hypercalcemia (E83.52)
|
|
|
| E21.0 |
Primary hyperparathyroidism
Hyperplasia of parathyroid
Osteitis fibrosa cystica generalisata [von Recklinghausen's disease of bone]
|
| E21.1 |
Secondary hyperparathyroidism, not elsewhere classified
| Excludes 1: |
secondary hyperparathyroidism of renal origin (N25.81)
|
|
| E21.2 |
Other hyperparathyroidism
Tertiary hyperparathyroidism
| Excludes 1: |
familial hypocalciuric hypercalcemia (E83.52)
|
|
| E21.3 |
Hyperparathyroidism, unspecified
|
| E21.4 |
Other specified disorders of parathyroid gland
|
| E21.5 |
Disorder of parathyroid gland, unspecified
|
|
| E22 |
Hyperfunction of pituitary gland [+]
| Excludes 1: |
Cushing's syndrome (E24.-)
Nelson's syndrome (E24.1)
overproduction of ACTH not associated with Cushing's disease (E27.0)
overproduction of pituitary ACTH (E24.0)
overproduction of thyroid-stimulating hormone (E05.8-)
|
|
|
| E22.0 |
Acromegaly and pituitary gigantism
Overproduction of growth hormone
| Excludes 1: |
constitutional gigantism (E34.4)
constitutional tall stature (E34.4)
increased secretion from endocrine pancreas of growth hormone-releasing hormone (E16.8)
|
|
| E22.1 |
Hyperprolactinemia
| Use additional |
code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5) |
|
| E22.2 |
Syndrome of inappropriate secretion of antidiuretic hormone
|
| E22.8 |
Other hyperfunction of pituitary gland
Central precocious puberty
|
| E22.9 |
Hyperfunction of pituitary gland, unspecified
|
|
| E23 |
Hypofunction and other disorders of the pituitary gland [+]
| Includes: |
the listed conditions whether the disorder is in the pituitary or the hypothalamus
|
| Excludes 1: |
postprocedural hypopituitarism (E89.3)
short stature due to endocrine disorder (E34.3-)
|
|
|
| E23.0 |
Hypopituitarism
Fertile eunuch syndrome
Hypogonadotropic hypogonadism
Idiopathic growth hormone deficiency
Isolated deficiency of gonadotropin
Isolated deficiency of growth hormone
Isolated deficiency of pituitary hormone
Kallmann's syndrome
Lorain-Levi short stature
Necrosis of pituitary gland (postpartum)
Panhypopituitarism
Pituitary cachexia
Pituitary insufficiency NOS
Pituitary short stature
Sheehan's syndrome
Simmonds' disease
|
| E23.1 |
Drug-induced hypopituitarism
| Use additional |
code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5) |
|
| E23.2 |
Diabetes insipidus
| Excludes 1: |
nephrogenic diabetes insipidus (N25.1)
|
|
| E23.3 |
Hypothalamic dysfunction, not elsewhere classified
| Excludes 1: |
Prader-Willi syndrome (Q87.11)
Russell-Silver syndrome (Q87.19)
|
|
| E23.6 |
Other disorders of pituitary gland
Abscess of pituitary
Adiposogenital dystrophy
|
| E23.7 |
Disorder of pituitary gland, unspecified
|
|
| E24 |
Cushing's syndrome [+]
| Excludes 1: |
congenital adrenal hyperplasia (E25.0)
|
|
|
| E24.0 |
Pituitary-dependent Cushing's disease
Overproduction of pituitary ACTH
Pituitary-dependent hypercorticalism
|
| E24.1 |
Nelson's syndrome
|
| E24.2 |
Drug-induced Cushing's syndrome
| Use additional |
code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5) |
|
| E24.3 |
Ectopic ACTH syndrome
|
| E24.4 |
Alcohol-induced pseudo-Cushing's syndrome
|
| E24.8 |
Other Cushing's syndrome
|
| E24.9 |
Cushing's syndrome, unspecified
|
|
| E25 |
Adrenogenital disorders [+]
| Includes: |
adrenogenital syndromes, virilizing or feminizing, whether acquired or due to adrenal hyperplasia consequent on inborn enzyme defects in hormone synthesis
Female adrenal pseudohermaphroditism
Female heterosexual precocious pseudopuberty
Male isosexual precocious pseudopuberty
Male macrogenitosomia praecox
Male sexual precocity with adrenal hyperplasia
Male virilization (female)
|
| Excludes 1: |
indeterminate sex and pseudohermaphroditism (Q56)
chromosomal abnormalities (Q90-Q99)
|
|
|
| E25.0 |
Congenital adrenogenital disorders associated with enzyme deficiency
Congenital adrenal hyperplasia
21-Hydroxylase deficiency
Salt-losing congenital adrenal hyperplasia
|
| E25.8 |
Other adrenogenital disorders
Idiopathic adrenogenital disorder
| Use additional |
code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5) |
|
| E25.9 |
Adrenogenital disorder, unspecified
Adrenogenital syndrome NOS
|
|
| E26 |
Hyperaldosteronism [+]
|
|
| E26.0 |
Primary hyperaldosteronism [+]
|
|
| E26.01 |
Conn's syndrome
| Code also |
adrenal adenoma (D35.0-)
|
|
| E26.02 |
Glucocorticoid-remediable aldosteronism
Familial aldosteronism type I
|
| E26.09 |
Other primary hyperaldosteronism
Primary aldosteronism due to adrenal hyperplasia (bilateral)
|
|
| E26.1 |
Secondary hyperaldosteronism
|
| E26.8 |
Other hyperaldosteronism [+]
|
|
|
| E26.9 |
Hyperaldosteronism, unspecified
Aldosteronism NOS
Hyperaldosteronism NOS
|
|
| E27 |
Other disorders of adrenal gland [+]
|
|
| E27.0 |
Other adrenocortical overactivity
Overproduction of ACTH, not associated with Cushing's disease
Premature adrenarche
| Excludes 1: |
Cushing's syndrome (E24.-)
|
|
| E27.1 |
Primary adrenocortical insufficiency
Addison's disease
Autoimmune adrenalitis
| Excludes 1: |
Addison only phenotype adrenoleukodystrophy (E71.528)
amyloidosis (E85.-)
tuberculous Addison's disease (A18.7)
Waterhouse-Friderichsen syndrome (A39.1)
|
|
| E27.2 |
Addisonian crisis
Adrenal crisis
Adrenocortical crisis
|
| E27.3 |
Drug-induced adrenocortical insufficiency
| Use additional |
code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5) |
|
| E27.4 |
Other and unspecified adrenocortical insufficiency [+]
| Excludes 1: |
adrenoleukodystrophy [Addison-Schilder] (E71.528)
Waterhouse-Friderichsen syndrome (A39.1)
|
|
|
| E27.40 |
Unspecified adrenocortical insufficiency
Adrenocortical insufficiency NOS
Hypoaldosteronism
|
| E27.49 |
Other adrenocortical insufficiency
Adrenal hemorrhage
Adrenal infarction
|
|
| E27.5 |
Adrenomedullary hyperfunction
Adrenomedullary hyperplasia
Catecholamine hypersecretion
|
| E27.8 |
Other specified disorders of adrenal gland
Abnormality of cortisol-binding globulin
|
| E27.9 |
Disorder of adrenal gland, unspecified
|
|
| E28 |
Ovarian dysfunction [+]
| Excludes 1: |
isolated gonadotropin deficiency (E23.0)
postprocedural ovarian failure (E89.4-)
|
|
|
| E28.0 |
Estrogen excess
| Use additional |
code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5) |
|
| E28.1 |
Androgen excess
Hypersecretion of ovarian androgens
| Use additional |
code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5) |
|
| E28.2 |
Polycystic ovarian syndrome
Sclerocystic ovary syndrome
Stein-Leventhal syndrome
|
| E28.3 |
Primary ovarian failure [+]
| Excludes 1: |
pure gonadal dysgenesis (Q99.1)
Turner's syndrome (Q96.-)
|
|
|
| E28.31 |
Premature menopause [+]
|
|
| E28.310 |
Symptomatic premature menopause
Symptoms such as flushing, sleeplessness, headache, lack of concentration, associated with premature menopause
|
| E28.319 |
Asymptomatic premature menopause
Premature menopause NOS
|
|
| E28.39 |
Other primary ovarian failure
Decreased estrogen
Resistant ovary syndrome
|
|
| E28.8 |
Other ovarian dysfunction
Ovarian hyperfunction NOS
| Excludes 1: |
postprocedural ovarian failure (E89.4-)
|
|
| E28.9 |
Ovarian dysfunction, unspecified
|
|
| E29 |
Testicular dysfunction [+]
| Excludes 1: |
androgen insensitivity syndrome (E34.5-)
azoospermia or oligospermia NOS (N46.0-N46.1)
isolated gonadotropin deficiency (E23.0)
Klinefelter's syndrome (Q98.0-Q98.1, Q98.4)
|
|
|
| E29.0 |
Testicular hyperfunction
Hypersecretion of testicular hormones
|
| E29.1 |
Testicular hypofunction
Defective biosynthesis of testicular androgen NOS
5-delta-Reductase deficiency (with male pseudohermaphroditism)
Testicular hypogonadism NOS
| Use additional |
code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5) |
| Excludes 1: |
postprocedural testicular hypofunction (E89.5)
|
|
| E29.8 |
Other testicular dysfunction
|
| E29.9 |
Testicular dysfunction, unspecified
|
|
| E30 |
Disorders of puberty, not elsewhere classified [+]
|
|
| E30.0 |
Delayed puberty
Constitutional delay of puberty
Delayed sexual development
|
| E30.1 |
Precocious puberty
Precocious menstruation
| Excludes 1: |
Albright (-McCune) (-Sternberg) syndrome (Q78.1)
central precocious puberty (E22.8)
congenital adrenal hyperplasia (E25.0)
female heterosexual precocious pseudopuberty (E25.-)
male isosexual precocious pseudopuberty (E25.-)
|
|
| E30.8 |
Other disorders of puberty
Premature thelarche
|
| E30.9 |
Disorder of puberty, unspecified
|
|
| E31 |
Polyglandular dysfunction [+]
| Excludes 1: |
ataxia telangiectasia [Louis-Bar] (G11.3)
dystrophia myotonica [Steinert] (G71.11)
pseudohypoparathyroidism (E20.1)
|
|
|
| E31.0 |
Autoimmune polyglandular failure
Schmidt's syndrome
|
| E31.1 |
Polyglandular hyperfunction
| Excludes 1: |
multiple endocrine adenomatosis (E31.2-)
multiple endocrine neoplasia (E31.2-)
|
|
| E31.2 |
Multiple endocrine neoplasia [MEN] syndromes [+]
Multiple endocrine adenomatosis
| Code also |
any associated malignancies and other conditions associated with the syndromes
|
|
|
| E31.20 |
Multiple endocrine neoplasia [MEN] syndrome, unspecified
Multiple endocrine adenomatosis NOS
Multiple endocrine neoplasia [MEN] syndrome NOS
|
| E31.21 |
Multiple endocrine neoplasia [MEN] type I
Wermer's syndrome
|
| E31.22 |
Multiple endocrine neoplasia [MEN] type IIA
Sipple's syndrome
|
| E31.23 |
Multiple endocrine neoplasia [MEN] type IIB
|
|
| E31.8 |
Other polyglandular dysfunction
|
| E31.9 |
Polyglandular dysfunction, unspecified
|
|
| E32 |
Diseases of thymus [+]
| Excludes 1: |
aplasia or hypoplasia of thymus with immunodeficiency (D82.1)
myasthenia gravis (G70.0)
|
|
|
| E32.0 |
Persistent hyperplasia of thymus
Hypertrophy of thymus
|
| E32.1 |
Abscess of thymus
|
| E32.8 |
Other diseases of thymus
| Excludes 1: |
aplasia or hypoplasia with immunodeficiency (D82.1)
thymoma (D15.0)
|
|
| E32.9 |
Disease of thymus, unspecified
|
|
| E34 |
Other endocrine disorders [+]
| Excludes 1: |
pseudohypoparathyroidism (E20.1)
|
|
|
| E34.0 |
Carcinoid syndrome [+]
| Code also |
the underlying disorder, such as:
primary neuroendocrine tumors (C7A.-)
secondary neuroendocrine tumors (C7B.-)
|
|
|
| E34.00 |
Carcinoid syndrome, unspecified
Carcinoid disease, unspecified
|
| E34.01 |
Carcinoid heart syndrome
Carcinoid heart disease
Hedinger syndrome
|
| E34.09 |
Other carcinoid syndrome
Carcinoid disease NEC
Carcinoid syndrome NEC
Other carcinoid disease
|
|
| E34.1 |
Other hypersecretion of intestinal hormones
|
| E34.2 |
Ectopic hormone secretion, not elsewhere classified
| Excludes 1: |
ectopic ACTH syndrome (E24.3)
|
|
| E34.3 |
Short stature due to endocrine disorder [+]
| Excludes 1: |
achondroplastic short stature (Q77.4)
hypochondroplastic short stature (Q77.4)
nutritional short stature (E45)
pituitary short stature (E23.0)
progeria (E34.8)
renal short stature (N25.0)
Russell-Silver syndrome (Q87.19)
short-limbed stature with immunodeficiency (D82.2)
short stature (child) (R62.52)
short stature in specific dysmorphic syndromes - code to syndrome - see Alphabetical Index
short stature NOS (R62.52)
|
|
|
| E34.30 |
Short stature due to endocrine disorder, unspecified
|
| E34.31 |
Constitutional short stature
Constitutional delay of growth, puberty, or maturation
|
| E34.32 |
Genetic causes of short stature [+]
|
|
| E34.321 |
Primary insulin-like growth factor-1 (IGF-1) deficiency
Acid-labile subunit gene (IGFALS) defect
Growth hormone gene 1 (GH1) defect with growth hormone neutralizing antibodies
Growth hormone insensitivity syndrome (GHIS)
Insulin-like growth factor 1 gene (IGF1) defect
Laron type short stature
Severe primary insulin-like growth factor-1 deficiency (SPIGFD)
Signal transducer and activator of transcription 5B gene (STAT5b) defect
|
| E34.322 |
Insulin-like growth factor-1 (IGF-1) resistance
Genetic syndrome with resistance to insulin-like growth factor-1
Insulin-like growth factor-1 receptor (IGF-1R) defect
Post-insulin-like growth factor-1 receptor signaling defect
|
| E34.328 |
Other genetic causes of short stature
Short stature due to ACAN gene variant
Short stature due to aggrecan deficiency
Short stature due to NPR-2 gene variant
|
| E34.329 |
Unspecified genetic causes of short stature
|
|
| E34.39 |
Other short stature due to endocrine disorder
|
|
| E34.4 |
Constitutional tall stature
Constitutional gigantism
|
| E34.5 |
Androgen insensitivity syndrome [+]
|
|
| E34.50 |
Androgen insensitivity syndrome, unspecified
Androgen insensitivity NOS
|
| E34.51 |
Complete androgen insensitivity syndrome
Complete androgen insensitivity
de Quervain syndrome
Goldberg-Maxwell syndrome
|
| E34.52 |
Partial androgen insensitivity syndrome
Partial androgen insensitivity
Reifenstein syndrome
|
|
| E34.8 |
Other specified endocrine disorders
Pineal gland dysfunction
Progeria
| Excludes 2: |
pseudohypoparathyroidism (E20.1)
|
|
| E34.9 |
Endocrine disorder, unspecified
Endocrine disturbance NOS
Hormone disturbance NOS
|
|
| E35 |
Disorders of endocrine glands in diseases classified elsewhere
| Code first |
underlying disease, such as:
late congenital syphilis of thymus gland [Dubois disease] (A50.59)
|
| Use additional |
code, if applicable, to identify: |
| Use additional |
sequelae of tuberculosis of other organs (B90.8) |
| Excludes 1: |
Echinococcus granulosus infection of thyroid gland (B67.3)
meningococcal hemorrhagic adrenalitis (A39.1)
syphilis of endocrine gland (A52.79)
tuberculosis of adrenal gland, except calcification (A18.7)
tuberculosis of endocrine gland NEC (A18.82)
tuberculosis of thyroid gland (A18.81)
Waterhouse-Friderichsen syndrome (A39.1)
|
|